Notice 9 Jul 2025 compliance, texas, dea, drug enforcement, medical licensing

❌DEA Revokes Registration

The Drug Enforcement Administration (DEA) has issued an Order to Show Cause against Andrew Jones, M.D., leading to the revocation of his DEA registrations due to lack of state authority to handle controlled substances in Texas. The ruling underscores the critical compliance requirements for medical professionals regarding state and federal regulations.

Learn More
Notice 9 Jul 2025 compliance, healthcare, regulation, new mexico, dea, drug enforcement, physician assistant

💊DEA Revokes Registration of Practitioner John Hanley, P.A.

The Drug Enforcement Administration has issued an Order to Show Cause proposing the revocation of John Hanley, P.A.'s registration, citing lack of authority to handle controlled substances in New Mexico due to the revocation of his physician assistant license. The Agency finds Registrant's default and confirms the necessity of state licensing for DEA registration, ruling the revocation effective immediately.

Learn More
Notice 8 Jul 2025 compliance, healthcare, regulation, fraud, registration, dea, florida, healthcare programs

🚫DEA Revokes Registration for Healthcare Fraud

The Drug Enforcement Administration has revoked the registration of Mark Agresti, M.D., due to healthcare fraud convictions. The order highlights the implications of mandatory exclusions from Medicare and Medicaid, emphasizing the stringent standards required for trustworthiness among healthcare providers and the consequences of failing to meet these standards.

Learn More
Notice 8 Jul 2025 regulatory compliance, healthcare, dea, drug enforcement, illinois, nursing

🚫DEA Revocation of Nurse Practitioner’s Registration

The Drug Enforcement Administration issued an Order to Show Cause proposing the revocation of Tanya Newlove's registration for handling controlled substances due to the expiration of her state nursing licenses. The agency highlights the critical requirement for practitioners to maintain valid state authority to dispense controlled substances, indicating significant compliance issues.

Learn More
Notice 8 Jul 2025 compliance, healthcare, medical license, dea, drug enforcement, state regulation, physician

⚖️DEA Revokes Physician's Registration

The Drug Enforcement Administration has issued a decision revoking the DEA registration of Dr. William Washington due to his lack of authority to practice medicine in Washington State. The order emphasizes the requirement for physicians to maintain state licensing to handle controlled substances, impacting compliance standards within the healthcare sector.

Learn More
Notice 7 Jul 2025 compliance, healthcare, ohio, dea, drug enforcement, medical regulation

⚖️DEA Revokes Registration of Dr. Loretta Clement - Key Outcomes

The Drug Enforcement Administration has revoked Dr. Loretta Clement's registration to prescribe and handle controlled substances due to her inactive medical license in Ohio. This action underscores the imperative for medical professionals to maintain proper state licensing to operate legally under federal law, reflecting ongoing regulatory enforcement in the healthcare sector.

Learn More
Notice 7 Jul 2025 regulation, business compliance, chemical industry, dea, drug enforcement

🏭Proposed Information Collection Under Chemical Diversion Control Act

The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.

Learn More
Notice 7 Jul 2025 regulatory compliance, business operations, chemical manufacturing, dea, drug enforcement

🧪Annual Reporting Requirements for Chemical Manufacturers by DEA

The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.

Learn More
Notice 7 Jul 2025 regulatory compliance, dea, drug enforcement, business registration, narcotic treatment

💊DEA Notice on Narcotic Treatment Program Registration Requirements

The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.

Learn More
Notice 1 Jul 2025 compliance, regulation, dea, controlled substances, chemical preparations

⚗️DEA Notice on Exempt Chemical Preparations

The applications for exempt chemical preparations received by the Drug Enforcement Administration between March 1, 2023, and March 31, 2025, as listed below, were accepted for filing and have been approved or denied as indicated.

Learn More